FDA.reportPublic FDA data

Application 063277

Type
ANDA
Sponsor
FRESENIUS KABI USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DOXORUBICIN HYDROCHLORIDEDOXORUBICIN HYDROCHLORIDEINJECTABLE;INJECTION2MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
63323-101Doxorubicin HydrochlorideDOXORUBICIN HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent
63323-101Doxorubicin HydrochlorideDOXORUBICIN HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent
63323-883Doxorubicin HydrochlorideDOXORUBICIN HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent
63323-883Doxorubicin HydrochlorideDOXORUBICIN HYDROCHLORIDEFresenius Kabi USA, LLCANDACurrent